These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 17039953)
41. Is the device development process adequate. Somberg JC Am J Ther; 2010; 17(2):123-4. PubMed ID: 20305398 [No Abstract] [Full Text] [Related]
42. A US FDA medical device update, Part II. Donawa ME Med Device Technol; 1996 Sep; 7(7):12-6, 18. PubMed ID: 10163518 [TBL] [Abstract][Full Text] [Related]
43. Pharmaceuticals and Medical Devices: Medical Devices. Berry MD; Issue Brief Health Policy Track Serv; 2015 Dec; ():1-64. PubMed ID: 27116798 [No Abstract] [Full Text] [Related]
44. Device safety and effectiveness. Somberg J Am J Ther; 2010; 17(4):357. PubMed ID: 20634652 [No Abstract] [Full Text] [Related]
45. Pharmaceuticals and medical devices: medical devices. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-23. PubMed ID: 19297720 [No Abstract] [Full Text] [Related]
46. Vioxx, radiology, and the Food and Drug Administration. Pentecost MJ J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841 [No Abstract] [Full Text] [Related]
47. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule. Food and Drug Administration, HHS Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946 [TBL] [Abstract][Full Text] [Related]
48. FDA flexes muscle in oversight of medical devices, technologies. Cruise C Biomed Instrum Technol; 2011; 45(2):105-8. PubMed ID: 21466325 [No Abstract] [Full Text] [Related]
49. U.S. medical device reporting: who is responsible? Donawa M Med Device Technol; 2005 Apr; 16(3):27-9. PubMed ID: 15871421 [TBL] [Abstract][Full Text] [Related]
50. Medical device technology user fees. Bailey PG Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834 [TBL] [Abstract][Full Text] [Related]
51. Medical device development. Panescu D Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():5591-4. PubMed ID: 19964134 [TBL] [Abstract][Full Text] [Related]
52. US guidance on formatting 510(k)s. Donawa M Med Device Technol; 2006 Mar; 17(2):27-9. PubMed ID: 16610716 [TBL] [Abstract][Full Text] [Related]
53. Software process improvement for the medical industry. McCaffery F; Donnelly P; McFall D; Wilkie FG Stud Health Technol Inform; 2005; 117():117-24. PubMed ID: 16282661 [TBL] [Abstract][Full Text] [Related]
54. Medical devices; effective date of requirement for premarket approval for a class III preamendments obstetrical and gynecological device. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Jul; 65(129):41330-2. PubMed ID: 11067678 [TBL] [Abstract][Full Text] [Related]
55. Food and Drug Administration control of medical devices: an inescapable intrusion and stimulus for adaptation. Friedman EA ASAIO J; 1998; 44(4):239-40. PubMed ID: 9682946 [No Abstract] [Full Text] [Related]
56. Forces reshaping the performance and contribution of the U.S. medical device industry. Benson JS Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326 [No Abstract] [Full Text] [Related]
57. Purchasing silicone. Pryce T Med Device Technol; 1996 Mar; 7(2):22-6, 28. PubMed ID: 10184584 [TBL] [Abstract][Full Text] [Related]
58. Medical devices: the obvious, the readily-accepted, and the surprising. Tolomeo DE; Clarke LA J Health Life Sci Law; 2008 Jul; 1(4):117, 119-44. PubMed ID: 18717154 [TBL] [Abstract][Full Text] [Related]
59. Use and recognition of consensus standards in US premarket submissions. Donawa ME Med Device Technol; 1999 Mar; 10(2):13-7. PubMed ID: 10387610 [TBL] [Abstract][Full Text] [Related]
60. Medical device development: from prototype to regulatory approval. Kaplan AV; Baim DS; Smith JJ; Feigal DA; Simons M; Jefferys D; Fogarty TJ; Kuntz RE; Leon MB Circulation; 2004 Jun; 109(25):3068-72. PubMed ID: 15226221 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]